After long political debates, the German parliament passed the new “Act on the Controlled Use of Cannabis” on 23 February 2024. From April 1 2024 on, adults over the age of 18 shall be allowed to possess and cultivate cannabis for personal use within certain limits. From July 2024 on...

The question of the legal use of cannabis and cannabis-containing products is currently on everyone's lips. Movements for the full legalisation of cannabis are making headlines repeatedly. But many other uses for cannabis that have become fashionable recently are also occupying the media and courts. Products containing cannabis, such as...

The debate on the legalisation on medical cannabis has intensified around the world in recent years. Countries like Portugal, Norway, the United Kingdom and Canada have regulations that authorise cannabis for specified medical uses. Likewise, the World Health Organization (WHO) has recognised the therapeutic properties of the substance through an...

Osborne Clarke has advised PharmaDrug, Inc. (Toronto, Canada) on its agreement dated May 31, 2022 with Khiron Life Sciences Corp. (Vancouver, Canada) to sell all of the outstanding shares in Pharmadrug Production GmbH, the company's wholly-owned German subsidiary. Pharmadrug Production GmbH is a medical cannabis distributor, with a schedule I...

Debate and controversy around cannabis and its derivatives are nothing new, with a wide array of legal frameworks and restrictions on its use in place around the world. In Europe, moves to change the legal status of cannabis and cannabidiol (CBD) have been gaining momentum in recent years, leading to...

The German government's plans to legalise cannabis for recreational purposes in Germany continue to move forward: after the governing coalition had agreed in the 2021 coalition agreement to allow the controlled dispensing of cannabis for recreational purposes to adults in licensed shops, the plans for introducing corresponding legislation have now...

Osborne Clarke advised Berlin-based cannabis pharmaceutical and consumer health Sanity Group on the USD 3.5 million investment of Snoop Dogg's Casa Verde Capital. The round was presented as a follow-on investment to the company’s USD 45 million Series A round announced in June of this year. After Sanity Group was...

Osborne Clarke has advised Aura Health Inc. on the acquisition of Pharmadrug Production GmbH. Aura has entered into a definitive share purchase agreement to acquire an 80% equity interest in the licenced medical cannabis distributor. The total purchase price for the acquisition is EUR 4.6 million. Aura will advance EUR...

Osborne Clarke advised cannabis start-up Sanity Group in a financing in which, among others, the US rapper and music producer Will.i.am, TV presenter Klaas Heufer-Umlauf and the soccer world champion Mario Götze invested in the Berlin based company. In total, the financing amounts to just under EUR 4 million. Other...

International legal practice Osborne Clarke has advised Sanity Group on its multi-million financing round with Holtzbrinck Ventures, Berlin-based Food-VC Atlantic Food Labs and Karan Wadhera, founder of the US cannabis fund Casa Verde. Various Business Angels also contributed to the financing round. Sanity Group is a start-up company focusing on...